Literature DB >> 3169268

Inhibition of glucose phosphorylation by fatty acids in the perfused rat heart.

J Chatham1, H F Gilbert, G K Radda.   

Abstract

The flux of glucose entering the glycolytic pathway under various metabolic conditions has been indirectly monitored in the Langendorff perfused rat heart using 31P-NMR spectroscopy. By totally inhibiting (greater than 95%) glyceraldehyde-3-phosphate dehydrogenase with low concentrations of iodoacetic acid (0.2 mM) in the perfusion medium, active glycolysis results in the accumulation of sugar phosphate species (fructose 1,6-bisphosphate, dihydroxyacetone phosphate, and glyceraldehyde 3-phosphate) which can be observed in the 31P-NMR spectrum. Using this technique, it has been shown that butyrate (10 mM) in the perfusion medium decreases the flux through the initial steps of the glycolytic pathway by at least 6-fold and that both glucose phosphorylation and glycogenolysis are inhibited. Upon total global ischemia in the presence of both glucose and butyrate, the glycolysis rate is stimulated approx. 100-fold.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169268     DOI: 10.1016/0014-5793(88)80529-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts.

Authors:  M C Corretti; Y Koretsune; H Kusuoka; V P Chacko; J L Zweier; E Marban
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  Mechanism of the diastolic dysfunction induced by glycolytic inhibition. Does adenosine triphosphate derived from glycolysis play a favored role in cellular Ca2+ homeostasis in ferret myocardium?

Authors:  H Kusuoka; E Marban
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

3.  Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.

Authors:  Álvaro Marín-Hernández; José S Rodríguez-Zavala; Isis Del Mazo-Monsalvo; Sara Rodríguez-Enríquez; Rafael Moreno-Sánchez; Emma Saavedra
Journal:  Front Physiol       Date:  2016-09-23       Impact factor: 4.566

4.  The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.

Authors:  Fabrice Ivanes; Danilo Faccenda; Jemma Gatliff; Ahmed A Ahmed; Stefania Cocco; Carol Ho Ka Cheng; Emma Allan; Claire Russell; Michael R Duchen; Michelangelo Campanella
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.